Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Titan Pharma (TTNP)

Titan Pharma (TTNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,236
  • Shares Outstanding, K 14,629
  • Annual Sales, $ 1,530 K
  • Annual Income, $ -8,780 K
  • 60-Month Beta 1.19
  • Price/Sales 15.15
  • Price/Cash Flow N/A
  • Price/Book 3.36
Trade TTNP with:

Options Overview Details

View History
  • Implied Volatility 137.06% ( -1,051.56%)
  • Historical Volatility 79.50%
  • IV Percentile 15%
  • IV Rank 8.60%
  • IV High 1,188.61% on 08/18/22
  • IV Low 38.09% on 02/16/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 693
  • Open Int (30-Day) 644

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -2.40
  • Growth Rate Est. (year over year) +41,725.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1800 +27.12%
on 07/26/22
1.5900 -5.66%
on 08/18/22
+0.2300 (+18.11%)
since 07/19/22
3-Month
0.3550 +322.54%
on 05/26/22
1.5900 -5.66%
on 08/18/22
+1.1150 (+289.61%)
since 05/19/22
52-Week
0.3496 +329.06%
on 05/19/22
2.3800 -36.97%
on 08/31/21
-0.6000 (-28.57%)
since 08/19/21

Most Recent Stories

More News
Titan Pharmaceuticals Announces Board Expansion and Management Changes

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board")...

TTNP : 1.4800 (-2.63%)
Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that the U.S. Food and Drug Administration ("FDA") has...

TTNP : 1.4800 (-2.63%)
Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist...

TTNP : 1.4800 (-2.63%)
Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), today filed a Schedule...

TTNP : 1.4800 (-2.63%)
Titan Pharmaceuticals: Q3 Earnings Snapshot

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Monday reported a loss of $1.9 million in its third quarter.

TTNP : 1.4800 (-2.63%)
Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has received funding from the Bill & Melinda...

TTNP : 1.4800 (-2.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical...

See More

Key Turning Points

3rd Resistance Point 1.6500
2nd Resistance Point 1.6200
1st Resistance Point 1.5700
Last Price 1.4800
1st Support Level 1.4900
2nd Support Level 1.4600
3rd Support Level 1.4100

See More

52-Week High 2.3800
Fibonacci 61.8% 1.6044
Last Price 1.4800
Fibonacci 50% 1.3648
Fibonacci 38.2% 1.1252
52-Week Low 0.3496

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar